Bisacodyl, docusate, lactulose, magnesium citrate/hydroxide/oxide, methylnaltrexone, naloxegol, plecanatide, polyethylene glycol 3350, and senna.
Pharmacologic Profile
General Use
To treat or prevent constipation or to prepare the bowel for radiologic or endoscopic procedures.
General Action and Information
Induce one or more bowel movements per day. Groups include stimulants (bisacodyl, senna), saline laxatives (magnesium salts), stool softeners (docusate), and osmotic cathartics (lactulose, polyethylene glycol). Methylnaltrexone and naloxegol are used to specifically manage opioid-induced constipation. Plecanatide is used to manage chronic constipation that is idiopathic in nature or due to irritable bowel syndrome. ↑ fluid intake, exercising, and adding more dietary fiber are also useful in the management of chronic constipation.
Contraindications
Hypersensitivity. Contraindicated in persistent abdominal pain, nausea, or vomiting of unknown cause, especially if accompanied by fever or other signs of an acute abdomen.
Precautions
Excessive or prolonged use may lead to dependence. Should not be used in children unless advised by a physician or other health care provider.
Interactions
Theoretically may ↓ the absorption of other orally administered drugs by ↓ transit time.
Nursing Implications
Assessment
Implementation
Patient/Family Teaching
Evaluation/Desired Outcomes